Delivery Order SPE2DB20D2014-SPE2DB25FC08C
- Not listed
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) on September 8, 2025, with completion targeted for September 29, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed-price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania facility and a completion deadline of September 4, 2025. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose 30-count supplies, with an ultimate completion date of August 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30 count). The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $41,540.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The delivery order, which represents a non-set-aside competitive award, is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by June 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $83,081.82 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This firm fixed price delivery order, which carries an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award...
- The Defense Logistics Agency awarded a $55,387.88 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30 count). This competitively awarded, non-set-aside contract operates under firm fixed pricing and is scheduled for completion by May 30, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). The contract, with an ultimate completion date of August 20, 2025, employs firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC08CDelivery Order
The Defense Logistics Agency awarded a $41,540.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit doses) on May 30, 2025, with completion scheduled for June 23, 2025. This is a non-set-aside competitive award, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices. This specific delivery order for Vyndamax, a neurological treatment medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.5k | 5/30/25 |